FDA Adopts Revised ICH Guideline on Quality in Clinical Trial Design
May 3, 2022
An international guideline focused on building quality into clinical trials is now official FDA guidance. The agency has published the International Council for Harmonization’s (ICH) E8(R1) — General Considerations for Clinical Studies as a final guidance, signaling its support for the “quality by design” concept.